<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36121546</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Progressive motor neuron syndromes with single CNS lesions and CSF oligoclonal bands: never forget solitary sclerosis!</ArticleTitle><Pagination><StartPage>6951</StartPage><EndPage>6954</EndPage><MedlinePgn>6951-6954</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-022-06407-y</ELocationID><Abstract><AbstractText>We describe 3 cases of solitary sclerosis (SS), a rare condition characterized by a single inflammatory demyelinating lesion in the white matter of the brain or spinal cord. All patients had progressive limb motor impairment (patient 1, 66-year-old female: left spastic hemiparesis; patient 2, 39-year-old male: right spastic hemiparesis; patient 3, 42-year-old female: proximally predominant left upper limb weakness with amyotrophy and fasciculations). In all patients, MRI disclosed a single small T2-hyperintense demyelinating lesion: in the right anterior paramedian upper medulla, in the median-left paramedian anterior lower medulla, and in the left paramedian anterior cervical spinal cord at C4 level, respectively. In patients 1 and 2, transcranial magnetic stimulation (TMS) demonstrated altered motor evoked potentials (MEPs) and increased central motor conduction time (CMCT) in the affected limbs; in patient 3, needle EMG revealed chronic neurogenic changes in C5-C7 muscles of left upper limb. Patients 1 and 2 had normal brain <sup>18</sup>F-fluorodeoxyglucose positron emission tomography (<sup>18</sup>F-FDG PET). CSF analysis demonstrated IgG oligoclonal bands in all patients. In patients 2 and 3, levels of neurofilament light chain (NFL) in CSF and serum, respectively, were within normal limits. The three cases were consistent with the diagnosis of SS. Notably, while the first two cases mimicked Mills' syndrome (the hemiparetic variant of primary lateral sclerosis, PLS), the third one was rather reminiscent of amyotrophic lateral sclerosis (ALS). This suggests including SS in the differential diagnosis not only of PLS, but also of ALS. We also report the first quantification of NFL levels in SS.</AbstractText><CopyrightInformation>&#xa9; 2022. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giacopuzzi Grigoli</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurology Residency Program, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinnante</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Imaging, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doneddu</LastName><ForeName>Pietro Emiliano</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neuroimmunology Unit, Humanitas Clinical and Research Center - IRCCS, Via Manzoni 56, 20089, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calcagno</LastName><ForeName>Narghes</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neurology Residency Program, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenti</LastName><ForeName>Sveva</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology Residency Program, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciammola</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maderna</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ticozzi</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Universit&#xe0; Degli Studi Di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellani</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nuclear Medicine Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beretta</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology Unit, Ospedale di Vimercate, Vimercate, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovaris</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Multiple Sclerosis Center, IRCCS Santa Maria Nascente - Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7698-3854</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Universit&#xe0; Degli Studi Di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verde</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3977-6995</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy. f.verde@auxologico.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Universit&#xe0; Degli Studi Di Milano, Milan, Italy. f.verde@auxologico.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043025">Oligoclonal Bands</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043025" MajorTopicYN="N">Oligoclonal Bands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012598" MajorTopicYN="N">Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009128" MajorTopicYN="N">Muscle Spasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010291" MajorTopicYN="N">Paresis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cerebrospinal fluid (CSF)</Keyword><Keyword MajorTopicYN="N">Demyelinating diseases</Keyword><Keyword MajorTopicYN="N">Motor neuron disease (MND)</Keyword><Keyword MajorTopicYN="N">Oligoclonal bands</Keyword><Keyword MajorTopicYN="N">Primary lateral sclerosis (PLS)</Keyword><Keyword MajorTopicYN="N">Solitary sclerosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>19</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36121546</ArticleId><ArticleId IdType="doi">10.1007/s10072-022-06407-y</ArticleId><ArticleId IdType="pii">10.1007/s10072-022-06407-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmalstieg WF, Keegan BM, Weinshenker BG (2012) Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. Neurology 78(8):540&#x2013;544. https://doi.org/10.1212/WNL.0b013e318247cc8c</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318247cc8c</ArticleId><ArticleId IdType="pubmed">22323754</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AJ et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162&#x2013;173. https://doi.org/10.1016/S1474-4422(17)30470-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30470-2</ArticleId><ArticleId IdType="pubmed">29275977</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR et al (2020) Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry 91(4):373&#x2013;377. https://doi.org/10.1136/jnnp-2019-322541</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322541</ArticleId><ArticleId IdType="pubmed">32029539</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiser SR, Mitra D, Williams TL, Baker MR (2019) Mills&#x2019; syndrome revisited. J Neurol 266(3):667&#x2013;679. https://doi.org/10.1007/s00415-019-09186-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09186-3</ArticleId><ArticleId IdType="pubmed">30631918</ArticleId><ArticleId IdType="pmc">6394692</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte G et al (2021) Amyotrophic lateral sclerosis phenotypes significantly differ in terms of magnetic susceptibility properties of the precentral cortex. Eur Radiol 31(7):5272&#x2013;5280. https://doi.org/10.1007/s00330-020-07547-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-07547-5</ArticleId><ArticleId IdType="pubmed">33399906</ArticleId></ArticleIdList></Reference><Reference><Citation>Claassen DO, Josephs KA, Peller PJ (2010) The stripe of primary lateral sclerosis: focal primary motor cortex hypometabolism seen on fluorodeoxyglucose F18 positron emission tomography. Arch Neurol 67(1):122&#x2013;125. https://doi.org/10.1001/archneurol.2009.298</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2009.298</ArticleId><ArticleId IdType="pubmed">20065142</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrun C, Cohen M, Mondot L, Ayrignac X, Labauge P (2017) A case report of solitary sclerosis: this is really multiple sclerosis. Neurol Ther 6(2):259&#x2013;263. https://doi.org/10.1007/s40120-017-0082-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-017-0082-8</ArticleId><ArticleId IdType="pubmed">28840523</ArticleId><ArticleId IdType="pmc">5700904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen M, Lebrun C, Ayrignac X, Labauge P, Assouad R (2015) Solitary sclerosis: experience from three French tertiary care centres. Mult Scler 21(9):1216. https://doi.org/10.1177/1352458515570405</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458515570405</ArticleId><ArticleId IdType="pubmed">25680988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattanzi S, Logullo F, Di Bella P, Silvestrini M, Provinciali L (2014) Multiple sclerosis, solitary sclerosis or something else? Mult Scler 20(14):1819&#x2013;1824. https://doi.org/10.1177/1352458514535129</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458514535129</ArticleId><ArticleId IdType="pubmed">24852918</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathnasabapathi D, Elsone L, Krishnan A, Young C, Larner A, Jacob A (2015) Solitary sclerosis: progressive neurological deficit from a spatially isolated demyelinating lesion: a further report. J Spinal Cord Med 38(4):551&#x2013;555. https://doi.org/10.1179/2045772314Y.0000000283</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/2045772314Y.0000000283</ArticleId><ArticleId IdType="pubmed">25615515</ArticleId><ArticleId IdType="pmc">4612213</ArticleId></ArticleIdList></Reference><Reference><Citation>Keegan BM et al (2016) Progressive solitary sclerosis: gradual motor impairment from a single CNS demyelinating lesion. Neurology 87(16):1713&#x2013;1719. https://doi.org/10.1212/WNL.0000000000003235</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003235</ArticleId><ArticleId IdType="pubmed">27638926</ArticleId><ArticleId IdType="pmc">5085075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N et al (2013) Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations. J Neurol 260(1):85&#x2013;92. https://doi.org/10.1007/s00415-012-6589-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6589-0</ArticleId><ArticleId IdType="pubmed">22752089</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesse S et al (2011) Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. J Neurol 258(6):1034&#x2013;1041. https://doi.org/10.1007/s00415-010-5876-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5876-x</ArticleId><ArticleId IdType="pubmed">21188408</ArticleId></ArticleIdList></Reference><Reference><Citation>Gille B et al (2019) Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 45(3):291&#x2013;304. https://doi.org/10.1111/nan.12511</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12511</ArticleId><ArticleId IdType="pubmed">29908069</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>